Irinotecan And Bevacizumab Combined With Re-radiotherapy in Recurrent Glioblastoma
NCT05201326
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Recurrent Glioblastoma
Interventions
DRUG:
Bevacizumab，Irinotecan and Re-radiotherapy
Sponsor
Ruijin Hospital